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Tuberculosis (TB) has been one of the most important infectious 
diseases affecting mankind and still represents a plague on a 
global scale. In this narrative review the origins of tuberculosis 
are outlined, according to the evidence of paleopathology. In par-
ticular the first cases of human TB in ancient skeletal remains 
are presented, together with the most recent discoveries result-
ing from the paleomicrobiology of the tubercle bacillus, which 
provide innovative information on the history of TB. The paleo-
pathological evidence of TB attests the presence of the disease 
starting from Neolithic times. Traditionally, it was thought that TB 
has a zoonotic origin, being acquired by humans from cattle dur-
ing the Neolithic revolution. However, the biomolecular studies 
proposed a new evolutionary scenario demonstrating that human 
TB has a human origin. The researches show that the disease was 
present in the early human populations of Africa at least 70000 
years ago and that it expanded following the migrations of Homo 
sapiens out of Africa, adapting to the different human groups. The 
demographic success of TB during the Neolithic period was due to 
the growth of density and size of the human host population, and 
not the zoonotic transfer from cattle, as previously hypothesized. 
These data demonstrate a long coevolution of the disease and 
its human host. Understanding the changes of TB through time 
thanks to the advances in the field of paleopathology can help to 
solve the present problems and understand the future evolution 
of TB.
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Introduction
Tuberculosis (TB) is an infectious disease caused by 
bacteria of the Mycobacterium tuberculosis complex 
(MTBC), which includes M. tuberculosis, M. bovis, M. 
canettii, M. africanum, M. pinnipedii, M. microti, M. 
caprae, M. mungi and M. orygis. The first two strains 
are most frequently responsible for TB in humans [1]. 
Despite the efforts to reduce the burden of TB world-
wide and the progress in care and prevention, it is still a 
major global cause of disease and death [2]. 
Starting from the industrial era, TB became particularly 
diffused, favoured by the increased population density 
and the poor living conditions. Thanks to the improve-
ment of health status, alimentation and hygiene dur-
ing the 20th century in developed countries, the disease 
began to decrease its incidence; the introduction of the 
BCG (Bacillus Calmette-Guérin) vaccine in 1921 and 
the use of chemotherapeutic drugs efficacious against 
the infection, such as streptomycin and isoniazid in 1943 
and 1952 respectively, further decreased the incidence. 
However, despite being considered in the 80s of the 20th 
century as a conquered infection [3], TB still remains a 
plague on a global scale and is the top infectious killer 
globally by being present today in both developed and 
developing countries; it is estimated that a quarter of the 
world population (1.7 billion people) is infected with M. 
tuberculosis, 5-15% of which will develop the TB disease 
during their lifetime [4]. Statistics show that in 2016 TB 
was the underlying cause of 1.3 million deaths among 
HIV-negative people and furthermore was a contributing 
cause of 374,000 deaths among people with HIV [4]. 
Due to historical, social and geopolitical determinants, 
the regions with the highest rates of TB are Sub-Saharan 
Africa, South-East Asia and East Europe [5, 6]. The on-
ly available vaccine (BCG) is obtained from attenuated 
strains of M. bovis, but is not extensively effective; no 
other vaccines had been produced in the meantime [7]. 
Finally, the appearance of TB-strains that are resistant 
to antibiotics, in particular multi-drug and even totally 
drug-resistant strains, represents a real challenge in the 
struggle against the disease [8]. 
Paleopathology, the interdisciplinary field of research 
that focuses on the development of ancient diseases and 
their impact and distribution in past populations, togeth-
er with ancient DNA analyses, can provide important 
contributions to our knowledge of this major pathogen 
through the study of how TB evolved through time.
Early paleopathological and biomolecular 
evidences for TB in ancient skeletal 
remains 
The paleopathological evidence for TB is based on pri-
mary sources, such as the analysis of skeletal remains 
and mummified soft tissues. The diagnosis of TB can be 
considered reliable on the basis of specific skeletal fea-
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tures; these include characteristic changes to the spine, 
consisting in lytic lesions affecting the vertebral bodies 
with resulting ankylosis, body collapse and kyphosis 
(Pott’s disease); extraspinal unifocal lytic lesions with 
absence of new bone formation; single joint ankylosis, 
specially localised in the hip, knee and wrist; and new 
bone formation on the internal surface of the ribs [9, 10]. 
In the last decades, the development of the new field of 
palaeomicrobiology permitted in several cases further 
corroboration of the diagnosis through the detection 
of TB ancient DNA (aDNA); the latest technologies of 
high-throughput sequencing and metagenomics allowed 
us to obtain a complete picture of the pathogen in an-
cient human remains [10].
However, modern clinical data demonstrated that only 
1-5% of patients with pulmonary TB develops skeletal 
lesions [11]; therefore, it should be considered that the 
detection of TB in paleopathology is largely underesti-
mated [12].
The earliest human skeletal remains with paleopatho-
logical changes of TB date back to 8000-10000 years 
ago, corresponding to the Neolithic revolution, and 
come from the Near East. Before this period, a single 
controversial diagnosis of Leptomeningitis tuberculosa, 
in relation to non specific endocranial changes of the 
frontal bone of a fossil, has been attributed to a Homo 
erectus from Turkey dating from the middle Pleistocene 
(490000–510000 years BP) [13]; this could represent the 
most ancient example of TB in a human fossil, but this 
interpretation was questioned by other authors [14]. 
The most ancient animal case, which was confirmed by 
morphological and biomolecular analyses, is represent-
ed by a ca. 17000-year-old late Pleistocene long-horned 
extinct bison (Bison antiquus) enclosed in sediments 
from the Natural Trap Cave from Wyoming (United 
States). This fossil documents that TB was present in 
North America at least 20000 years BP, long before the 
domestication [15].
The most notable of the first TB traces in human skeletal 
remains are concentrated in the Near East and Europe.
As for the Near East, five cases from two sites located 
in the Fertile Crescent belonging to the Pre-Pottery Neo-
lithic B (PPNB) period provide evidence for the pres-
ence of human TB. Four individuals with lesions con-
sistent with TB were brought to light from Dja’de el 
Mughara, situated on the Euphrates river in Northern 
Syria and dating to the pre-domestication phase (8800-
8300 BC). An individual from Tell Aswad from South-
ern Syria, belonging to the early domestication phase 
(8200-7600 BC), displayed features typical of Hyper-
trophic Pulmonary Osteoarthropathy (HPOA), that is 
caused by chronic pulmonary diseases such as TB. In 
addition to the morphological features, multidisciplinary 
analyses such as morphological examination, MicroCT 
scan, lipid biomarkers and molecular analyses were also 
performed with positive diagnostic results on selected 
specimens from these archaeological sites, confirming 
the presence of human TB in the pre-domestication and 
early domestication phases of the Neolithic [16]. 
Another three cases evoking skeletal human TB were 
reported in the Neolithic village of Ain Ghazal in Jor-
dan, dated to 7250 BC and also located in the cradle of 
agriculture; these cases, whose diagnosis was only mor-
phological as no molecular analyses were performed, 
suggest the presence of human TB before and/or during 
the introduction of agriculture and animal domestica-
tion [17]. 
From the same geographical area, in the ancient Levan-
tine village of Atlit-Yam now submerged (Israel), there 
is a report of two cases of TB on the basis of scarce pa-
leopathological changes involving an adult individual 
and an adolescent, presumed to be mother and son, as 
they were buried together. The site is dated from 6200-
5500 BC, corresponding to the last phase of the Pre-
Pottery Neolithic period, when the transition to agricul-
ture and animal domestication was fully accomplished. 
Lipid biomarkers and molecular analyses confirmed the 
presence of TB in the two individuals [18, 19]. Lipid 
biomarkers examination consists in the extraction, deri-
vatisation and high-performance liquid chromatography 
(HPLC) analysis of mycobacterial cell wall mycolic ac-
ids [18, 19]. 
As for Europe, among the earliest cases of TB in skel-
etal evidence there are cases of tuberculous spondylitis 
(Pott’s disease) in two individuals from the Early Neo-
lithic belonging to the Linear Pottery culture (5400–
4800 BC) from three sites (Halberstadt, Derenburg and 
Karsdorf) from Saxony-Anhalt in central Germany. Mo-
lecular analyses detected the presence of pathogens be-
longing to the MTC in skeletal remains from all the three 
sites taken in examination [20].
Other cases with morphological evidences of TB were 
unearthed from several Neolithic sites dated back to 
5000 BC, including Heidelberg, Germany [22], Zlota, 
Poland [20], Hódmezēvásárhely-Gorzsa, Hungary (con-
firmed by lipid biomarker analyses and ancient DNA 
analysis) [23], Alsónyék-Bátaszék, Hungary (confirmed 
by molecular analyses) [24, 25], attesting to the diffu-
sion of the infection in different areas of Europe. 
A particular concentration of TB was observed in the 
Finalese area in Liguria (Northwestern Italy) belonging 
to the Middle Neolithic period (4000-3500 BC), where 
three cases were discovered in three important caves that 
are in close proximity to each other: Arene Candide [26], 
Arma dell’Aquila [27], and Pollera [28] caves. The diag-
nosis was based on typical skeletal lesions; biomolecular 
analyses using polymerase chain reaction (PCR) were 
performed on the Pollera case, but did not confirm the 
presence of the MTBC ancient DNA. 
As for Africa, 13 cases from the Upper Egyptian site 
of Nagada (4500-3000 BC) suggest that the earliest 
evidence of TB in Egypt could be dated back to 4500 
BC  [3]. The first Egyptian cases of TB confirmed by 
molecular analyses date back to the predynastic period 
(3500-2650 BC) and suggest that infection with M. tu-
berculosis was relatively recurrent in this period [29-33].
Outside the European landscape, a possible Neolithic 
case of TB was observed in an adult individual from 
Shanghai, China, associated with the Songze culture 
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(3900-3200 BC), at the beginning of the wet rice agri-
culture [34]. 
From the late Neolithic onward the paleopathological 
evidence of TB becomes more frequent. 
Finally, in the prehistoric New World, macroscopic and 
molecular analyses suggest that the earliest evidence of 
human TB in skeletal remains and mummified soft tis-
sues is attested in prehistoric South America in Peru by 
700 AD, while in North America it is attested by 900 AD 
in the Southwest, where large permanent agricultural 
settlements are concentrated [35, 36].
The biomolecular advancements  
on the origins of TB
As highlighted in the previous section, the paleopatho-
logical evidence of human TB attests the presence of the 
disease starting from Neolithic times; no sure skeletal 
cases are dated before this period [37]. However, ab-
sence of evidence does not mean evidence of absence. 
Did TB affect humans in more ancient times? When did 
TB become a human pathogen? Did human TB originate 
from animal TB? The new next-generation sequencing 
technologies tried to answer these questions [38, 39].
According to the traditional theory, formulated before 
the advent of the biomolecular studies, humans acquired 
TB from cattle during the Neolithic revolution due to 
the zoonotic transfer from the newly domesticated ani-
mals [40-42]. As several infectious diseases have a zoo-
notic origin, it was thought that TB was also transferred 
to humans from animals; in particular, M. bovis would 
have infected humans, then adapting and evolving into 
M. tuberculosis. This theory was supported by the fact 
that the oldest human remains presenting paleopatholog-
ical changes of TB were found in the Neolithic period, 
while the findings in animal remains have suggested a 
more ancestral existence of TB in cattle [15].
The evolutionary history of TB was dramatically 
changed by recent biomolecular studies that challenged 
the old theory, proposing an African origin for the MT-
BC long pre-dating the Neolithic [43, 44].
Phylogenetic studies have clarified that within MTB 
seven lineages, associated with different areas of the 
world, can be identified [46]: the Lineage 1 (East Africa, 
Philippines), the modern Euroasian lineages 2 (which 
includes the Beijing family), 3, 4 that are in close phy-
logenetic relationship, African lineages 5 and 6 with M. 
africanum phylogeographically distributed in West Af-
rica, and finally, the newly described lineage 7 [47] col-
lected from patients with TB from Ethiopia. Animal spe-
cies, including M. bovis, M. microti and M. pinnipedii, 
represent monophyletic lineages, and M. canettii has an 
ancestral position in the MTBC. The chronological posi-
tions of the lineages are determined by the presence or 
absence of an MTB-specific deletion (TbD1); the pres-
ence makes them ancestral (TbD1+), the absence makes 
them modern (TbD1-) [48, 49]. On this basis, lineages 
1, 5, and 6, the animal lineages and M. canettii repre-
sent the ancestral MTBC group, whereas lineages 2, 3 
and 4 are defined as modern from an evolutionary point 
of view, because they are thought to have diffused more 
recently; lineage 7 resulted as intermediate between an-
cient and modern MTB lineages. These findings suggest 
that the animal lineages and M. africanum have diverged 
from the progenitor of the ancestral MTB lineages and 
that the tubercle bacillus was originally a human patho-
gen [49], confirming previous studies which suggested 
that animal adapted MTBC strains diverged from the 
major MTBC strains [48, 43-45]. Therefore, the new 
evolutionary scenario proposed that the human TB did 
not derive from M. bovis, but that, on the contrary, MTB 
has a human origin. 
Furthermore, a recent work seems to confirm this theory 
with phylogenetic studies based on whole-genome data 
of MTCB. This study is based on the sequencing of a 
global collection of 259 MTBC modern clinical strains 
representative of the diversity of the global MTBC for 
reconstructing the phylogenetic relationship between 
them [50]. The overall results of three independent phy-
logenetic analyses for the determination of the most re-
cent common ancestor of TB using a Bayesian approach 
suggested East and West Africa as the most probable 
geographic origin of MTBC. The results of this research 
would show the common origin in Africa of Homo sapi-
ens and MTBC and that TB was present in the early hu-
man populations of Africa at least 70000 years ago, then 
infecting humans for thousands of years [50].
The study of Comas and colleagues [50] also would 
demonstrate that MTBC evolved in parallel with its 
human host. The disease expanded in correspondence 
with the migrations of Homo sapiens out of Africa. It 
has been hypothesized that the two M. africanum lin-
eages, M. canettii and lineage 7 might have remained in 
Africa, whereas the others could have reached Europe 
and Asia, following the colonization of these areas, and 
finally becoming endemic worldwide. This work would 
suggest that the different lineages have adapted to differ-
ent human groups. On the basis of this study a correla-
tion between the divergence of the Lineage 1 of MTBC 
about 67000 years ago and the first human wave of mi-
gration out of Africa that was directed around the Indian 
Ocean was observed. Another split of MTBC that would 
have occurred 46000 years ago corresponds instead to 
the second great migration of Homo sapiens from Af-
rica, which was directed to Eurasia [50]. With the rise of 
Neolithic Demographic Transition 10000 ± 2000 years 
ago, TB raised its rate of diffusion together with the in-
crease in the human population density following the 
advance of agriculture and animal domestication. These 
results would suggest that the demographic success of 
TB during the Neolithic period was due to the growth of 
density and size of the human host population, and not to 
the zoonotic transfer from cattle, as previously hypoth-
esized [50].
Also, of interest is the study of the dispersal of the mod-
ern Lineage 2, which includes the “Bejing” strains that 
have an increased virulence and transmission potential, 
a shorter latency phase than ancient lineages, further-
more being particularly successful in geographical dif-
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fusion, and are associated with antibiotic resistance [8]. 
The study has evidenced that the dating of Lineage 2 
in Asia coincides with the arrival of the anatomically 
modern humans in East Asia about 42000-32000 years 
ago confirmed by the archaeological evidence. This lin-
eage presents a first expansion about 11000-6000 years 
ago corresponding to the development of agriculture in 
China about 8000 years ago and, later, a further expan-
sion about 5000-3000 years ago, when agriculture was 
introduced in the regions near China [50]. These results 
seem to show that tuberculosis had various moments of 
expansion other than the increase during the Neolithic in 
the Mediterranean region.
Furthermore, these data could explain why TB presents 
an adaptation to both low and high host population den-
sities. In fact, the high level of asymptomatic latency 
that allows reactivation of TB and the slow progression 
to disease are an indication of adaptation to low host 
population density that is consistent with the ancestral 
emergence of MTBC in Africa before the Neolithic 
revolution. On the other hand, the modality of aerosol 
transmission and the high virulence in order to guarantee 
the maximum level of transmission are typical of a high-
density population environment. This double adaptation 
would have ensured to the bacterium a large diffusion 
in both high- and low-density areas, resulting in the fact 
that one-third of the human population is infected but 
remains asymptomatic, representing an extraordinary 
reservoir for the bacterium [8].
The study of the origins and patterns of change in the 
evolution of MTBC would demonstrate that migration 
and demography of the anatomically modern humans af-
fected the evolution and spread of TB. The major recent 
molecular studies on the evaluation of its demography 
and timing of propagation seem to show a long coevolu-
tion of the disease and its human host, demonstrating 
that TB represents an exemplary model of adaptation to 
humans [8]. They also suggest that the palaeomicrobiol-
ogy of TB can be fully understood through an integrated 
approach in correlation-association with the human host 
genome sequencing, considering the relation between 
the evolution of TB genomes and their human hosts. 
Conclusions
TB was traditionally thought to be a zoonosis, but the 
advancements of biomolecular analyses performed by 
various teams of researchers seem to suggest that M. tu-
berculosis did not evolve from M. bovis, but has a com-
plex evolutionary history that reflects human evolution. 
In order to understand the evolution of the bacterium and 
the current epidemiology of TB it is necessary to inves-
tigate the history of the disease in parallel with that of 
humans. In fact, MTBC has evolved with humans during 
thousands of years, influencing reciprocally their evo-
lution. Understanding the changes of TB through time 
thanks to the advent of the next-generation sequencing 
technology can aid the problems of the present and fu-
ture evolution of TB in relationship with its human host.
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